Dermatol. praxi. 2015;9(1):6-12

Seborrheic dermatitis

MUDr.Milan Junášek
Dermatovenerologická ambulance, sálek-lasery-korekce, Praha

The article depicts actual findings in etiology, sums up clinical picture, and presents accessible forms of therapy and their combinations,

as well as possible prevention.

Keywords: seborrheic dermatitis, Mallasezia, lipase activity, cutaneous barrier disorder

Published: March 16, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Junášek M. Seborrheic dermatitis. Dermatol. praxi. 2015;9(1):6-12.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Alizahed N, et al. Comparison the efficacy of fluconazole and terbinafine in patients with moderate to severe seborrheic dermatitis. Dermatology Research And Practice, 2014, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948193/?report=classic. Go to original source...
    2. Benáková N. Ekzémy a dermatitidy. Praha, Maxdorf 2009.
    3. Buechner SA. Multicenter, double-blind, parallel group study investigating the non-inferiority of efficacy and safety of a 2% miconazole nitrate shampoo in comparison with a 2% ketoconazole shampoo in the treatment of seborrhoeic dermatitis of the scalp. The Journal of Dermatological Treatment, 2014; 25(3): 226-231. Go to original source...
    4. Caputo R, Barbareschi M. Itraconazole: new horizons. Giornale Italiano di Dermatologia e Venereologia. 2002: 137-181.
    5. Caputo R, Rigoni C, Vigo GP, De Doncer P, De Michelis P, Spinelli G, Oriani A, Barbareschi M. Oral treatment with itraconazole in patients with seborrhoeic dermatitis and pityriasis capitis: clinical, mycological and laboratory evalution. Journal of the American Academy of Dermatology 2000: 339.
    6. Cook BA, Warshaw EM. Role of Topical Calcineurin Inhibitors in the Treatment of Seborrheic Dermatitis. A Review of Pathophysiology, Safety, and Efficacy. American Journal of Clinical Dermatology 2009: 103-116. Go to original source... Go to PubMed...
    7. Crutchfield CE. Pimecrolimus: a new treatment for seborrheic dermatitis. Cutis 2002; 70(4): 207-208. Go to PubMed...
    8. Čapková Š. Dermatitis seborrhoica (seboroický ekzém) v ambulantní praxi. Forum medicinae 2000; 3: 72-75.
    9. Faerrgemann J. Treatment of Seborrhoeic Dermatitis with oral Terbinafine? Lancet 2001; 21: 170. Go to original source...
    10. Faerrgemann J, Bergbrant IM, Dohse M, Scott A, Westgate G. Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry. British Journal of Dermatology, 2001; 144(3): 549-556. Go to original source...
    11. Firooz A, Solhpour A, Gorouhi F, et al. Pimecrolimus cream, 1%, vs hydrocortisone acetate cream, 1%, in the treatment of facial seborrheic dermatitis; a randomized, investigator-blind, clinical trial. Archives of Dermatology 2006; 142: 1066-1067. Go to original source... Go to PubMed...
    12. Gupta AK, Nicol KA. Ciclopirox 1% shampoo for the treatment of seborrheic dermatitis. International Journal of Dermatology 2006; 45(1): 66-69. Go to original source...
    13. Gupta AK, Richardson M, Paquet M. Systematic review of oral treatments for seborrheic dermatitis. Journal of the European Academy of Dermatology and Venereology, 2014; 28(1): 16-26. Go to original source... Go to PubMed...
    14. Izzo CM, Qualliariello Via G. Seborrhoeic Dermatitis in HIV Infected Patients. Journal of Clinical Investigation 2002: 49-50.
    15. Kojanová M, Šuková T, Štork J. Dermatitis seborrhoica. Česko-slovenská dermatologie 2005; 80(5): 261-269.
    16. Lallas A, et al. Dermoscopic patterns of common facial inflammatory skin diseases. Journal Of The European Academy Of Dermatology And Venereology, 2014; 28(5): 609-614. Go to original source... Go to PubMed...
    17. Linder D, Dreiher J, Zampetti A, Sampogna F, Cohen AD. Seborrheic dermatitis and hypertension in adults: a cross-sectional study. Journal of the European Academy of Dermatology and Venereology, 2013 Nov 23, http://onlinelibra-ry.wiley.com/doi/10.1111/jdv.12310/abstract. Go to original source... Go to PubMed...
    18. Meshkinpour A, Sun J, Weinstein G. An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis. Journal of the American Academy of Dermatology 2003; 49(1): 145-147. Go to original source... Go to PubMed...
    19. Moises Alfaro CB, Caceres Rios HW, Rueda M, Velazquez Acosta A. Are Infantile Seborrheic and Atopic Dermatitis Clinical Variants of the Same Disease? International Journal of Dermatology 2002; 41(6): 349-351. Go to original source... Go to PubMed...
    20. Nakabayashi A, Sei Y, Guillot J. Identification of Malassezia species isolated from patiens with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Japanese Journal of Medical Mycology 2000; 38(5): 337-341. Go to original source... Go to PubMed...
    21. Orfanos CE, Zouboulis CC. Oral Retinoids in the Treatment of Seborrhoea and Acne. Dermatology 1988; 196(1): 140-147. Go to original source... Go to PubMed...
    22. Parry ME, Sharpe GR. Seborrhoeic dermatitis is not caused by an altered immune response to Malassezia yeast. British Journal of Dermatology 1998; 139(2): 254-263. Go to original source... Go to PubMed...
    23. Rigoupoulos D, Ioannides D, Kalogeromitros D, Gregoriou S, Katsambas A. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial. British Journal of Dermatology 2004; 151(5): 1071-1075. Go to original source... Go to PubMed...
    24. Roques C, Brousse S, Panizzutti C. In vitro antifungal efficacy of ciclopirox olamine alone and associated with zinc pyrithione compared to ketoconazole against Malassezia globosa and Malassezia restricta reference strains. Mycopathologia, 2006; 162(6): 395-400. Go to original source... Go to PubMed...
    25. Satchell AC, Saurajen A, Bell C, et al. Treatment of dandruff with 5% tea tree oil shampoo. Journal of the American Academy of Dermatology 2002; 47(6): 852-855. Go to original source... Go to PubMed...
    26. Scaparro E, Ouadri G, Virno G, Orifici C, Milani M. Evaluation of the Efficacy and Tolerability of Oral Terbinafine in Patients with Seborrhoeic Dermatitis. British Journal of Dermatology 2001; 144(4): 854-857. Go to original source... Go to PubMed...
    27. Schwartz JR, et al. A Comprehensive Pathophysiology of Dandruff and Seborrheic Dermatitis - Towards a More Precise Definition of Scalp Health. Acta Dermato-Venereologica, 2013; 93: 131-137. Go to original source... Go to PubMed...
    28. Schwartz JR, Clinton TS. Darier's disease misdiagnosed as severe seborrheic dermatitis. Military Medicine, 2011; 176(12): 1457-1459. Go to original source... Go to PubMed...
    29. Skořepová M. Dermatitis seborrhoica. Amireport 4-5/95: 23-25.
    30. Sosa M, Rojas F, Mangiaterra M, Giusiano G. Prevalence of Malassezia species associated with seborrheic dermatitis lesions in patients in Argentina. Revista Iberoamericana De Micología, 2013; 30(4): 239-242. Go to original source... Go to PubMed...
    31. Sugita T, Tajima M, Ito T, et al. Antifungal activities of tacrolimus and azole agents against the eleven currently accepted Malassezia species. Journal of Clinical Microbiology. 2005; 43(6): 2824-2829. Go to original source... Go to PubMed...
    32. Sugita T, Čang E, Tanaka T, Nišikawa A, Tadžima M, Cuboi R. Hito hifu džózai šinkin Malassezia no kinsó kaiseki ni kan suru up to date [Nejnovější analýza osídlení lidské kůže kvasinkami Malassezia]. Medical Mycology Journal, 2013; 54(1): 39-44. Go to original source... Go to PubMed...
    33. Viodé C, et al. Cathepsin S, a new pruritus biomarker in clinical dandruff/seborrhoeic dermatitis evaluation. Experimental Dermatology, 2014; 23(4): 274-275. Go to original source... Go to PubMed...
    34. Xu J, Saunders C, Hu P. Dandruff-associated Malassezia genomes reveal convergent and divergent virulence traits shared with plant and human fungal pathogens. Proceedings of the National Academy of Sciences USA 2007; 104(47): 18730-18735. Go to original source... Go to PubMed...
    35. Zarei-Mahmoudabadi A, Zarrin M, Mehdinezhad F. Seborrheic dermatitis due to Malassezia species in Ahvaz, Iran. Iranian Journal of Microbiology, 2013; 5(3): 268-271. Go to original source...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.